Temp
Background Image:
An NIH-sponsored clinical trial for people with scleroderma.
Living with
scleroderma?
The BRAVOS study may be an option for you.
Living with
The BRAVOS Study
A clinical trial evaluating
Brentuximab Vendotin treatment for Diffuse Cutaneous Systemic Sclerosis.
Am I Eligible?
If you are between the ages of 18-70 and have been diagnosed with progressive scleroderma within the past 5 years, you may be eligible to participate. Learn more.
Study Locations
Find a BRAVOS clinical research center near you. Click here.